ExodusPoint Capital Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-42,357
Closed -$2.46M – 2050
2026
Q2
$2.46M Sell
42,357
-83,470
-66% -$4.53M 0.02% 748
2026
Q1
$7.31M Buy
+125,827
New +$6.83M 0.06% 317
2021
Q4
– Sell
-14,300
Closed -$363K – 2494
2021
Q3
$363K Buy
+14,300
New +$347K ﹤0.01% 1539

Other funds holding PCVX

ExodusPoint Capital Management's PCVX Position: Q3 2026 in Review

ExodusPoint Capital Management sold out of Vaxcyte (PCVX) in Q3 2026, closing a stake of 42,357 shares — an estimated $2.46M sold.

ExodusPoint Capital Management first reported a position in PCVX in Q3 2021 and held it in 3 quarters. The position peaked at $7.31M in Q1 2026. 353 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • ExodusPoint Capital Management reported no remaining Vaxcyte position as of Q3 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 42,357 Vaxcyte shares in Q3 2026, an estimated $2.46M.
  • ExodusPoint Capital Management first reported a position in Vaxcyte in Q3 2021 and held it in 3 quarters.
  • ExodusPoint Capital Management's Vaxcyte position peaked at $7.31M in Q1 2026.
  • 353 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.